Abivax S.a.
Clinical trials sponsored by Abivax S.a., explained in plain language.
-
Four-year gut disease treatment trial seeks lasting relief
Disease control OngoingThis study follows people with moderate to severe ulcerative colitis who are already taking the experimental drug ABX464. It aims to check the long-term safety and effectiveness of taking 25mg of ABX464 once daily for up to 54 months. The research will monitor patients for side e…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New pill tested to control debilitating bowel disease for years
Disease control OngoingThis large, late-stage trial is testing whether a daily pill called ABX464 can safely keep ulcerative colitis under control long-term. It involves over 1,100 adults whose disease remains active despite trying standard medications. The study will measure if the drug can keep patie…
Phase: PHASE3 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC